Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement.
Edeling MA, Austin SK, Shrestha B, Dowd KA, Mukherjee S, Nelson CA, Johnson S, Mabila MN, Christian EA, Rucker J, Pierson TC, Diamond MS, Fremont DH.
Edeling MA, et al. Among authors: pierson tc.
PLoS Pathog. 2014 Apr 17;10(4):e1004072. doi: 10.1371/journal.ppat.1004072. eCollection 2014 Apr.
PLoS Pathog. 2014.
PMID: 24743696
Free PMC article.